肠道微生物群作为肝细胞癌中的生物标志物和治疗标
Betul Gok Yavuz1, Saumil Datar2, Shadi Chamseddine3
1Department of Medicine, University of Missouri, St. Louis, MO 63121, USA.
Cancers
|October 14, 2023
概括
肠道微生物群影响肝细胞癌 (HCC) 的发展和治疗. 肠道微生物群生物标志物对早期HCC检测和预测免疫疗法反应有希望.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 肠道微生物群通过调节免疫和炎症反应,在健康和疾病中发挥着至关重要的作用.
- 肝细胞癌 (HCC) 是一种主要的全球性癌症,受到肠肝轴相互作用的显著影响.
- 肠道微生物组成越来越多地被认为对癌症发育和治疗疗效的影响.
研究的目的:
- 审查肠道微生物组在肝细胞癌 (HCC) 中的作用.
- 探索肠道微生物群作为HCC的诊断和预测生物标志物的潜力.
- 评估肠道微生物群作为治疗策略,特别是在HCC免疫治疗中.
主要方法:
- 对肠道微生物组和HCC研究的文献综述.
- 分析了小鼠模型和人类研究,研究肠肝轴.
- 对肠道微生物群生物标志物和免疫疗法的当前研究进行评估.
主要成果:
- 肠道微生物组的组成与HCC的发展和进展有关.
- 肠道微生物群生物标志物为非侵入性HCC检测提供了潜在的潜力.
- 微生物群的组成可以预测对癌症免疫疗法的反应.
结论:
- 肠道微生物组是HCC发病的一个重要因素.
- 肠道微生物群分析对早期HCC诊断和预后充满希望.
- 准肠道微生物组代表了HCC的新治疗途径,特别是免疫疗法.
更多相关视频
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
36
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
36
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K